Authors
Latest:
The Road Less Traveled: Nontraditional Work Arrangements in AcademiaAccording to the 2014 National Pharmacist Workforce Study, approximately 18.7% of women and 16.4% of men actively engaged as pharmacists reported working part-time.
Latest:
Practice-Changing Data Revealed for Premenopausal HR+ Breast CancerFindings presented at 50th Annual Meeting of ASCO show aromatase inhibitor effective for premenopausal women when combined with ovarian function suppression.
Latest:
Optimizing Treatment Regimens for Multiple Sclerosis: The Pharmacist's Role in Advancing Patient CareThis Continuing Education activity is supported by educational grants from Sanofi-Aventis US Genzyme and Novartis Pharmaceuticals Corporation.
Latest:
Detecting Signs of Opioid Abuse and Treating the AddictionKnowing the warning signs and establishing trust are crucial to identifying and treating the opioid abuser.
Latest:
Systemic Therapy Options for Treating HR+/HER2– Metastatic Breast CancerFollowing initial breast cancer diagnosis by mammography, MRI, or ultrasound, treatment is largely based upon the histologic subtype and staging of the tumor(s).
Latest:
Trends in Statin Treatment Costs and Potential Impact of Novel TherapiesGeneric atorvastatin led to an increase in generic dispensing rate and a reduction in the cost of treatment for patients requiring cholesterol-lowering treatment. The upcoming introduction of the PCSK9 inhibitor may change this trend.
Latest:
Fostering Rapid Innovation During a Time of CrisisPromoting an environment that allows for rapid problem-solving and execution under high stress is essential to face problems that are poorly understood and yet require rapid change.
Latest:
Implications of STeP for Improved Diabetes Control: A Payer PerspectiveImplementation of the STeP program across managed care organizations could lead to improved patient outcomes and significant cost savings.
Latest:
Manufacturer Reimbursement Support Programs Raise Legal Questions For Specialty PharmaciesNavigating insurance coverage for specialty drugs has always been a complex and fundamental part of the specialty drug distribution chain.
Latest:
Rheumatoid Arthritis and Joint Replacement: Impact of BiologicsSince the introduction of biologics to treat rheumatoid arthritis, there has been a reduction in total hip and total knee replacement surgeries among rheumatoid arthritis patients.
Latest:
Pursuing a Path With the FDAAs a pharmacy student in Washington DC, I have had the privilege of being exposed to a number of opportunities available for pharmacists who wish to work in the federal government.
Latest:
New-Generation CephalosporinsSince their discovery in the 1950s, cephalosporins have become one of the largest classes of antibiotics.
Latest:
Type 3 Diabetes: An Alias for Alzheimer's Disease?Impairment in insulin and insulin growth factor seems to play a role in the development of Alzheimer's disease.
Latest:
Pregabalin Prior Authorization and Potential Medication-Medication and Medication-Condition InteractionsThis study of patients treated with pregabalin or duloxetine found that pregabalin prior authorization policies were associated with increased exposure to potential medication-medication and medication-condition interactions.
Latest:
Patient Engagement and Wellness: A Critical Piece of the Puzzle as Health Care Moves to Value-Based ModelsAlthough we have seen some progress through the proliferation of patient-centered medical homes, most clinicians have not fundamentally altered their basic approach to engaging with their patients.
Latest:
June 2023 Interactive Case StudiesCases highlight patients who have attention-deficity/hyperactivity disorder and diabetic peripheral nephropathy.
Latest:
Varicella-Zoster Virus: An Ounce of Prevention Does Not Equal a CureThe impact of varicella-zoster virus vaccination programs on the US population is not yet clear.
Latest:
Contact DermatitisContact dermatitis is among the most common inflammatory skin conditions encountered by clinicians.
Latest:
Utility of Antithrombotic Therapy in Chronic Systolic Heart FailureThe primary care physician for a 67-year-old female patient with hypertension, dyslipidemia, and chronic non-ischemic systolic heart failure wants to know whether to initiate an antithrombotic agent.
Latest:
Preventing Medication Errors in PharmacyHow to avoid common errors in pharmacies to protect patients.
Latest:
Medicare Part D Insulin Tiering Change: Impact on Health OutcomesThis study explores the impact of a Medicare Part D formulary tier change, specifically with respect to branded insulin products, on insulin adherence, hemoglobin A1C, and diabetes-related events in elderly diabetic beneficiaries strategies for selection of appropriate and cost-effective therapy will also be discussed.
Latest:
Annual Stroke Costs to Health Plans Among Atrial Fibrillation PatientsAn incidence-based model was developed to estimate the annual ischemic and hemorrhagic stroke–related healthcare costs to a hypothetical US health plan with 1 million enrollees.
